- Home
- CALM vs AXSM Comparison
CALM vs AXSM Comparison
Compare CALM & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALM
- AXSM
- Stock Information
- Founded
- CALM 1957
- AXSM 2012
- Country
- CALM United States
- AXSM United States
- Employees
- CALM N/A
- AXSM N/A
- Industry
- CALM Farming/Seeds/Milling
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- CALM Consumer Staples
- AXSM Health Care
- Exchange
- CALM Nasdaq
- AXSM Nasdaq
- Market Cap
- CALM 4.9B
- AXSM 5.1B
- IPO Year
- CALM 1996
- AXSM 2015
- Fundamental
- Price
- CALM $105.94
- AXSM $111.70
- Analyst Decision
- CALM Sell
- AXSM Strong Buy
- Analyst Count
- CALM 3
- AXSM 17
- Target Price
- CALM $86.67
- AXSM $171.65
- AVG Volume (30 Days)
- CALM 791.5K
- AXSM 618.2K
- Earning Date
- CALM 07-22-2025
- AXSM 08-04-2025
- Dividend Yield
- CALM 1.79%
- AXSM N/A
- EPS Growth
- CALM 258.93
- AXSM N/A
- EPS
- CALM 20.24
- AXSM N/A
- Revenue
- CALM $3,799,016,000.00
- AXSM $432,157,000.00
- Revenue This Year
- CALM $76.88
- AXSM $62.57
- Revenue Next Year
- CALM N/A
- AXSM $59.96
- P/E Ratio
- CALM $5.22
- AXSM N/A
- Revenue Growth
- CALM 60.00
- AXSM 72.16
- 52 Week Low
- CALM $63.37
- AXSM $72.21
- 52 Week High
- CALM $116.41
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- CALM 64.42
- AXSM 58.82
- Support Level
- CALM $98.31
- AXSM $108.48
- Resistance Level
- CALM $105.82
- AXSM $113.48
- Average True Range (ATR)
- CALM 2.74
- AXSM 3.35
- MACD
- CALM 0.33
- AXSM 0.69
- Stochastic Oscillator
- CALM 81.34
- AXSM 76.10
About CALM Cal-Maine Foods Inc.
Cal-Maine Foods Inc produces and sells shell eggs. Its main market is the United States. The company's product portfolio contains nutritionally enhanced, cage-free, organic, and brown eggs. Cal-Maine Foods markets the shell eggs to a diverse group of customers, including grocery-store chains, club stores, and food service distributors. The company's brands are Egg-Land's, Land O' Lakes, Farmhouse, and 4-Grain. The Company has one reportable operating segment, which is the production, grading, packaging, marketing and distribution of shell eggs.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.